4//SEC Filing
Pearce Samantha 4
Accession 0001805688-25-000003
CIK 0001232524other
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 6:40 PM ET
Size
6.8 KB
Accession
0001805688-25-000003
Insider Transaction Report
Form 4
Pearce Samantha
EVP, Chief Commercial Officer
Transactions
- Award
Ordinary Shares
2025-01-17+2,533→ 26,777 total - Tax Payment
Ordinary Shares
2025-01-17$122.62/sh−1,365$167,376→ 25,412 total
Footnotes (3)
- [F1]Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2022. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2025, which represents the date on which the level of performance attained was certified.
- [F2]The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 29, 2024.
- [F3]Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001805688
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 6:40 PM ET
- Size
- 6.8 KB